Israeli researchers discovered a new genetic approach that may stop the spread of brain cancer.

 

Brain metastases are the final, lethal consequence of many aggressive cancers, and researchers are racing to discover preventive measures.

A new Tel Aviv University study finds a known adjuvant — an ingredient used in some vaccines to strengthen the immune response —may be an effective means of preventing brain metastases in patients whose primary tumors have been removed. Continue reading